In vivo measurements of the cerebral perfusion and cardiovascular effects of the novel guanidine ME10092 in the non-human primate, Papio ursinus

This publication has 13 references indexed in Scilit:

• Synthesis and Quantitative Structure−Activity Relationship of Hydrazones ofN-Amino-N‘-hydroxyguanidine as Electron Acceptors for Xanthine Oxidase
  Journal of Medicinal Chemistry, 2004
• The novel guanidine ME10092 protects the heart during ischemia–reperfusion
  European Journal of Pharmacology, 2002
• Alpha-2 Adrenoceptor Activity Affects Propofol-Induced Sleep Time
  Anesthesia & Analgesia, 2002
• Neuroprotective effect of aminoguanidine on transient focal ischaemia in the rat brain
  Brain Research, 2001
• N-Hydroxyguanidine Compound 1-(3,4-Dimethoxy- 2-chlorobenzylideneamino)-3-hydroxyguanidine Inhibits the Xanthine Oxidase Mediated Generation of Superoxide Radical
  Archives of Biochemistry and Biophysics, 2000
• Reperfusion injury: Experimental evidence and clinical implications
  American Heart Journal, 1999
• Identification of an N‐hydroxyguanidine reducing activity of xanthine oxidase
  European Journal of Biochemistry, 1998
• A fresh look at reperfusion injury
  Cardiovascular Research, 1998
• A Minimum Dose of Clonidine Added to Mepivacaine Prolongs the Duration of Anesthesia and Analgesia After Axillary Brachial Plexus Block
  Anesthesia & Analgesia, 1996
• The Conversion of Xanthine Dehydrogenase to Xanthine Oxidase and the Role of the Enzyme in Reperfusion Injury1
  The Journal of Biochemistry, 1994